{"DataElement":{"publicId":"3045387","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy Response Evaluation Criteria in Solid Tumors Type","preferredDefinition":"A description of the best response to therapy according to the Response Evaluation Criteria in Solid Tumors.","longName":"2946463v1.0:3063768v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2946463","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Having the most positive qualities._The result of therapy for a given disease or condition in a patient or group of patients.","longName":"2404658v1.0:3194600v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3194600","version":"1","preferredName":"Best Outcome of Therapy","preferredDefinition":"Having the most positive qualities.:The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C25432:C18919","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome of Therapy","conceptCode":"C18919","definition":"The result of therapy for a given disease or condition in a patient or group of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D80CD45-BE7A-5B19-E040-BB89AD430E80","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-02","modifiedBy":"ONEDATA","dateModified":"2011-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"747EBAC6-25E8-A734-E040-BB89AD43588E","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3063768","version":"1","preferredName":"Response Evaluation Criteria in Solid Tumors Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)_Type; a subdivision of a particular kind of thing.","longName":"3063768v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete response","valueDescription":"Complete response","ValueMeaning":{"publicId":"3261517","version":"1","preferredName":"Complete response","longName":"3261517","preferredDefinition":"Disappearance of all target lesions for a period of at least one month","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA3BED77-D9F0-8A24-E040-BB89AD430FA9","latestVersionIndicator":"Yes","beginDate":"2011-08-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA3BED77-DA09-8A24-E040-BB89AD430FA9","beginDate":"2010-04-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"ONEDATA","dateModified":"2011-08-11","deletedIndicator":"No"},{"value":"Not assessed","valueDescription":"Negation Assessment","ValueMeaning":{"publicId":"3049794","version":"1","preferredName":"Negation Assessment","longName":"3049794","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"836E0020-994D-2647-E040-BB89AD435E03","latestVersionIndicator":"Yes","beginDate":"2010-04-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2010-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA3BED77-DA40-8A24-E040-BB89AD430FA9","beginDate":"2010-04-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"ONEDATA","dateModified":"2011-08-11","deletedIndicator":"No"},{"value":"Partial response","valueDescription":"Partial response","ValueMeaning":{"publicId":"3261519","version":"1","preferredName":"Partial response","longName":"3261519","preferredDefinition":"At least 30 percent decrease in the sum of the longest diameter of measured lesions (target lesions) taking as reference the baseline sum of longest diameters","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA3BED77-DA61-8A24-E040-BB89AD430FA9","latestVersionIndicator":"Yes","beginDate":"2011-08-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA3BED77-DA7A-8A24-E040-BB89AD430FA9","beginDate":"2010-04-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"ONEDATA","dateModified":"2011-08-11","deletedIndicator":"No"},{"value":"Progressive disease","valueDescription":"Progressive disease","ValueMeaning":{"publicId":"3261520","version":"1","preferredName":"Progressive disease","longName":"3261520","preferredDefinition":"At least a 20 percent increase in the sum of the longest diameter of measured lesions (target lesions), taking as reference the smallest sum of the longest diameters recorded since the treatment started or the appearance of one or more new lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA3BED77-DA84-8A24-E040-BB89AD430FA9","latestVersionIndicator":"Yes","beginDate":"2011-08-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA3BED77-DA9D-8A24-E040-BB89AD430FA9","beginDate":"2010-04-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"ONEDATA","dateModified":"2011-08-11","deletedIndicator":"No"},{"value":"Stable disease","valueDescription":"Stable disease","ValueMeaning":{"publicId":"3261521","version":"1","preferredName":"Stable disease","longName":"3261521","preferredDefinition":"Neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD, taking as reference the smallest sum of the longest diameters since the treatment started","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA3BED77-DAA7-8A24-E040-BB89AD430FA9","latestVersionIndicator":"Yes","beginDate":"2011-08-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA3BED77-DAC0-8A24-E040-BB89AD430FA9","beginDate":"2010-04-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"ONEDATA","dateModified":"2011-08-11","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA3BED77-DACA-8A24-E040-BB89AD430FA9","beginDate":"2010-04-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"ONEDATA","dateModified":"2011-08-11","deletedIndicator":"No"},{"value":"Therapy / Immune induced complete response","valueDescription":"Therapeutic Procedure And/Or Immune Induction Complete Remission","ValueMeaning":{"publicId":"3280087","version":"1","preferredName":"Therapeutic Procedure And/Or Immune Induction Complete Remission","longName":"3280087","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.: Used to indicate that either or both of two items or options: Protected against infectious disease by either specific or non-specific mechanisms. (On-line Medical Dictionary): The act of bringing about something.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Immune","conceptCode":"C17997","definition":"Protected against infectious disease by either specific or non-specific mechanisms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD131F50-493B-F4C8-E040-BB89AD436985","latestVersionIndicator":"Yes","beginDate":"2011-09-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD131F50-4954-F4C8-E040-BB89AD436985","beginDate":"2011-09-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-16","modifiedBy":"ONEDATA","dateModified":"2011-09-16","deletedIndicator":"No"},{"value":"Complete response with persistent imaging abnormalities of unknown significance","valueDescription":"Complete response unknown","ValueMeaning":{"publicId":"3261518","version":"1","preferredName":"Complete response unknown","longName":"3261518","preferredDefinition":"Complete response with persistent imaging abnormalities of unknown significance","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA3BED77-DA13-8A24-E040-BB89AD430FA9","latestVersionIndicator":"Yes","beginDate":"2011-08-11","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-08-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B162D7A9-F9C6-985C-E040-BB89AD43752E","beginDate":"2010-04-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-10","modifiedBy":"ONEDATA","dateModified":"2011-11-10","deletedIndicator":"No"},{"value":"Toxic Death","valueDescription":"Therapy-Related Toxicity Death","ValueMeaning":{"publicId":"3345073","version":"1","preferredName":"Therapy-Related Toxicity Death","longName":"3345073","preferredDefinition":"The finding of bodily harm due to the poisonous effects associated with the action or administration of therapeutic agents.: The absence of life or state of being dead.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy-Related Toxicity","conceptCode":"C42607","definition":"The finding of bodily harm due to the poisonous effects associated with the action or administration of therapeutic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"CASP1 Gene","conceptCode":"C26554","definition":"This gene plays a role in apoptosis, inflammation, septic shock, and wound healing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B5E2C84B-6EB0-CE4C-E040-BB89AD435B04","latestVersionIndicator":"Yes","beginDate":"2012-01-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B62CEE81-2D31-66A6-E040-BB89AD430254","beginDate":"2011-11-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-01-10","modifiedBy":"ONEDATA","dateModified":"2012-01-10","deletedIndicator":"No"},{"value":"Not evaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3AE04B4-8CA7-8533-E040-BB89AD43135A","beginDate":"2011-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-09","modifiedBy":"ONEDATA","dateModified":"2011-12-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3272579","version":"1","preferredName":"Response Evaluation Criteria in Solid Tumors Type","preferredDefinition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com):Type; a subdivision of a particular kind of thing.","longName":"C49164:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Response Evaluation Criteria in Solid Tumors","conceptCode":"C49164","definition":"Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve (\"respond\"), stay the same (\"stable\"), or worsen (\"progression\") during treatments. (from www.recist.com)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACEA336D-9BE1-9D02-E040-BB89AD43428D","latestVersionIndicator":"Yes","beginDate":"2011-09-14","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-09-14","modifiedBy":"ONEDATA","dateModified":"2011-09-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"84984555-833D-434E-E040-BB89AD4374EC","latestVersionIndicator":"Yes","beginDate":"2010-04-19","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2010-04-19","modifiedBy":"KUMMEROA","dateModified":"2012-03-26","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964912","version":"1","longName":"2120r1: Breast Cancer Post-HSCT Data","context":"NHLBI"},{"publicId":"2964891","version":"1","longName":"2020r1: Breast Cancer Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964914","version":"1","longName":"2124r1: Sarcoma Post-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"},{"publicId":"3279257","version":"1","longName":"2127r1: Renal Carcinoma Post-HSCT Data","context":"NHLBI"},{"publicId":"3279256","version":"1","longName":"2123r1: Ovarian Cancer Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"bc_post_tx_bst_rspn_nobn","type":"NMDP_FN","context":"NHLBI"},{"name":"bc_base_tx_bst_rspn_nobn","type":"NMDP_FN","context":"NHLBI"},{"name":"oc_post_dx_status_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"sar_post_dx_best_rspns_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"rcc_post_tx_best_response","type":"NMDP_FN","context":"NHLBI"},{"name":"bc_post_dx_bst_rspn_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"oc_post_tx_best_resp","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:diseaseStatusCode ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"form text","type":"Alternate Question Text","description":"Non-Bone Response Code:","url":null,"context":"NHLBI"},{"name":"What was the best outcome of","type":"Preferred Question Text","description":"What was the best outcome of therapy according to the Response Evaluation Criteria in Solid Tumors?","url":null,"context":"NHLBI"},{"name":"What was the best  response to HSCT?","type":"Alternate Question Text","description":"What was the best  response to HSCT?","url":null,"context":"NHLBI"},{"name":"What was the best non-bone response?","type":"Alternate Question Text","description":"What was the best non-bone response?","url":null,"context":"NHLBI"},{"name":"Best response to line of therapy:","type":"Alternate Question Text","description":"Best response to line of therapy:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:3045387","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.diseaseStatusCode WHERE PerformedDiagnosis > AssessedResultRelationship > PerformedObservation > PerformedClinicalinterpretation.value = \"best result\" AND PerformedDiagnosis.value(ANY=>ST) = \"specified non-bone disorder\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"83399500-E0E5-CA6D-E040-BB89AD434BAA","latestVersionIndicator":"Yes","beginDate":"2010-04-01","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2010-04-01","modifiedBy":"KUMMEROA","dateModified":"2021-06-17","changeDescription":".2021-6-17 ak System generated def displayed as alt def. 6/18/12: added AQT for F2020.wz","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}